ArcherDx acquired by Mass.-based Enzymatics in deal worth up to $50M

ArcherDx acquired by Mass.-based Enzymatics in deal worth up to $50M

BOULDER - ArcherDX, a Boulder developer of NGS-based kits and software solutions for use in investigating cancer, has been acquired by Massachusetts-based Enzymatics Inc., a producer of reagents,... Read More

By: InnovatioNews Monday September 9, 2013 0 comments Tags: ArcherDx, Boulder, Enzymatics, Jon DiVincenzo